Positive Phase 1 data for Promitil     Early finish in China for surufatinib    Making gold out of lead    Mapping a new mechanism    Targeting tough tumors    Triple combination study shows promise    So far, so good    TG4010 to be retired    Drugging the undruggable    Cologuard mechanism tested for liver cancer    OB-002 shrinks tumors, bone metastases    A G-NK cell therapy collaboration    Grey Wolf Therapeutics makes £2.5 million in Series A2    Meeting a new mechanism    New year, new deal    A clinical carcinoma collaboration    I-Mab moves in multiple myeloma    EMA acceptance for Lumoxiti    Congratulating a clearance    An oncology duo deal    Modeling mantle cell    Compugen presents preclinical data for COM902     Accelerating a novel glioma therapeutic    Combo shows promise    A focus on fusions    Triple-agent regimen improves survival    Dynamic combo    Inhale, exhale and predict    Cancer Research News Focus Feature: Oncology--Stem to stern    Plectin’s biomarker role grows

Next-Generation Biological Models: Revolutionizing Cancer Research   Quanterix, Delivering Ultrasensitive Biomarker Measurement You Can Count On   Uniform, Size-Controlled 3D Spheroid Cultures TTP Labtech Webinar: Miniaturization and Automation of Single Cell RNAseq Library at UCSD   How to use the Avant Mini-Extruder   Next Generation SPR Analysis with Pioneer Platform (pall) Using iCell GlutaNeurons for Safety Pharmacology and Drug Discovery   An Introduction to Analytical Ultracentrifugation (AUC)   Producing and Purifying Viral Systems in the Laboratory with Centrifugation

PAGE UTILITIES PRINT CURRENT PAGE SEND THIS PAGE TO A COLLEAGUE CONTACT US DDNEWS Published by Old River Publications LLC 19035 Old Detroit Road Rocky River, OH USA 44116 Ph: 440-331-6600  |  Fax: 440-331-7563

Home  |   About Us  |   Editor's Choice  |   News  |   Opinion  |   Top 5  |   Video  |   Links

© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.